Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 23,109 | -64,583 | -4,229 | N/A | -20,720 |
| Depreciation Amortization | 158 | 2,749 | 60 | N/A | 510 |
| Accounts receivable | -92 | 15 | 99 | N/A | N/A |
| Other Working Capital | -556 | 1,016 | -151 | N/A | 1,420 |
| Other Operating Activity | -35,191 | 54,511 | -60 | 0 | 8,490 |
| Operating Cash Flow | $-12,572 | $-6,292 | $-4,281 | $N/A | $-10,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,202 | -102 | -53 | N/A | -660 |
| Other Investing Activity | 0 | 0 | 3,150 | 0 | 0 |
| Investing Cash Flow | $-1,202 | $-102 | $3,097 | $N/A | $-660 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 18,887 | 950 | N/A | N/A |
| Other Financing Activity | 0 | 7,000 | 0 | 0 | -250 |
| Financing Cash Flow | $N/A | $25,887 | $950 | $N/A | $-250 |
| Beginning Cash Position | 20,355 | 862 | 1,096 | N/A | 16,440 |
| End Cash Position | 6,581 | 20,355 | 862 | N/A | 5,210 |
| Net Cash Flow | $-13,774 | $19,493 | $-234 | $N/A | $-11,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,572 | -6,292 | -4,281 | N/A | -10,300 |
| Capital Expenditure | -1,202 | -102 | -53 | N/A | N/A |
| Free Cash Flow | -13,774 | -6,394 | -4,334 | 0 | -10,300 |